ZA200108438B - Adipocyte complement related protein homolog zacrp2. - Google Patents

Adipocyte complement related protein homolog zacrp2.

Info

Publication number
ZA200108438B
ZA200108438B ZA200108438A ZA200108438A ZA200108438B ZA 200108438 B ZA200108438 B ZA 200108438B ZA 200108438 A ZA200108438 A ZA 200108438A ZA 200108438 A ZA200108438 A ZA 200108438A ZA 200108438 B ZA200108438 B ZA 200108438B
Authority
ZA
South Africa
Prior art keywords
zacrp2
related protein
protein homolog
complement related
adipocyte complement
Prior art date
Application number
ZA200108438A
Inventor
Christopher S Piddington
Paul D Bishop
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of ZA200108438B publication Critical patent/ZA200108438B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
ZA200108438A 1999-04-20 2001-10-15 Adipocyte complement related protein homolog zacrp2. ZA200108438B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29507299A 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
ZA200108438B true ZA200108438B (en) 2002-08-28

Family

ID=23136091

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108438A ZA200108438B (en) 1999-04-20 2001-10-15 Adipocyte complement related protein homolog zacrp2.

Country Status (9)

Country Link
EP (1) EP1171599A1 (en)
JP (1) JP2002541846A (en)
AU (1) AU4468600A (en)
CA (1) CA2370602A1 (en)
IL (1) IL146011A0 (en)
MX (1) MXPA01010540A (en)
NO (1) NO20015114L (en)
WO (1) WO2000063376A1 (en)
ZA (1) ZA200108438B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002044373A2 (en) * 2000-11-29 2002-06-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp12
JP2004517635A (en) * 2000-11-29 2004-06-17 ザイモジェネティクス，インコーポレイティド Adipocyte complement associated with the protein ZACRP13

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (en) * 1997-08-06 2002-07-12 Genset Sa LSR COMPLEX RECEPTOR, ACTIVITY, CLONING, AND APPLICATION TO DIAGNOSIS, PREVENTION AND / OR TREATMENT OF OBESITY AND THE RISKS OR COMPLICATIONS THEREOF
CA2327317A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
JP2003527067A (en) * 1998-05-21 2003-09-16 スミスクライン ビーチャム コーポレーション ACRP30R1L, a homologue of ACRP30 (30 KD adipocyte complement-related protein)

Also Published As

Publication number Publication date
IL146011A0 (en) 2002-07-25
JP2002541846A (en) 2002-12-10
CA2370602A1 (en) 2000-10-26
NO20015114D0 (en) 2001-10-19
EP1171599A1 (en) 2002-01-16
MXPA01010540A (en) 2002-06-04
WO2000063376A1 (en) 2000-10-26
AU4468600A (en) 2000-11-02
NO20015114L (en) 2001-12-19

Similar Documents

Publication Publication Date Title
ZA991544B (en) Dental abrasive.
ZA987844B (en) Therapeutic combinations.
MXPA01013362A (en) ANTI-alphav.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200105690B (en) Novel treatment.
MXPA00007601A (en) Timer.
IL145971A0 (en) Adipocyte complement related protein homolog zacrp3
ZA200204156B (en) Water treatment.
ZA200110454B (en) Pharmaceutical complex.
ZA200006750B (en) Prosthesis System.
AU2002246535A1 (en) Adipocyte complement related protein zacrp13
ZA200108438B (en) Adipocyte complement related protein homolog zacrp2.
ES1047984Y (en) ORTHODONTICS CORK.
GB0029720D0 (en) I.S machine7544232001
ZA200110046B (en) Therapeutic agents.
AU5037100A (en) Adipocyte complement related protein homolog zacrp6
GB9927681D0 (en) Protein
AU2002226033A1 (en) Adipocyte complement related protein zacrp3x2
IL150134A0 (en) Apoptin-associating protein
EP1146053A4 (en) Meg-4 protein
ZA200204581B (en) Nitro-sulfobenzamides.